Kilian Witzel joined Avid Bioservices in the beginning of 2022 and is responsible for the Assay Development for all cell and gene therapy products produced at Avid. He has over 10 years of experience in analytical development for biologics. Furthermore, Mr. Witzel has extensive experience in method validation as well as in in-process, release, and quality control testing of biomolecules.